HealthVerity Blog

How RWE can support drug development during COVID-19 and beyond: Q&A with Dr. Diana Brainard of Gile...

The COVID-19 pandemic introduced novel challenges for global biopharma organizations, as many adapted their clinical trial operations while working to develop lifesaving interventions. At Gilead Sciences, this need to quickly pivot led to an increase...

How RWE can support drug development during COVID-19 and beyond: Q&A with Dr. Diana Brainard of Gile...

The COVID-19 pandemic introduced novel challenges for global biopharma organizations, as many adapted their clinical tri...

The role of RWE: Longitudinal patient insights bridging clinical and real-world data

COVID-19 has heightened the need for an expanded understanding of clinical trial populations and patient insights both d...

Thought leadership

2021 Data Imperatives: The pulse of the industry

The healthcare industry relies on real-world data more and more to make informed and effective decisions and the COVID-1...

Thought leadership

HVPCI reports positive swing to patient confidence as the year comes to a close

December, 2020 - Philadelphia, PA - HealthVerity announced the most recent update to its HealthVerity Patient Confidence...

Thought leadership

HVPCI notes a 5-point dip as COVID-19 restrictions tighten and telehealth fatigue sets in

November 24, 2020 - Philadelphia, PA - HealthVerity announced the most recent update to its HealthVerity Patient Confide...

The modern way to data: Design, build and implement your data strategy

Building a modern data infrastructure within today’s healthcare enterprise is challenging on many levels. Your organizat...

Thought leadership

HVPCI reports “98” and marks six-month milestone of patient monitoring amid COVID-19 pandemic

October 19, 2020 - Philadelphia, PA - HealthVerity announced the most recent update to its HealthVerity Patient Confiden...

How RWE can support drug development during COVID-19 and beyond: Q&A with Dr. Diana Brainard of Gile...

How RWE can support drug development during COVID-19 and beyond: Q&A with Dr. Diana Brainard of Gilead Sciences

How RWE can support drug development during COVID-19 and beyond: Q&A with Dr. Diana Brainard of Gile...

The role of RWE: Longitudinal patient insights bridging clinical and real-world data

2021 Data Imperatives: The pulse of the industry

HVPCI reports positive swing to patient confidence as the year comes to a close

HVPCI notes a 5-point dip as COVID-19 restrictions tighten and telehealth fatigue sets in

The modern way to data: Design, build and implement your data strategy

HVPCI reports “98” and marks six-month milestone of patient monitoring amid COVID-19 pandemic

Subscribe to the HealthVerity blog